Researchers were successful in correcting mutations that cause CF in human organoids. They were previously formed by the same research team from stem cells of patients with CF and stored at a biobank in Utrecht. A procedure termed as prime editing was used to replace the altered DNA fragment that causes CF with a healthy strand of DNA in these organoids. Advanced editing new version o... https://www.coherentmarketinsights.com/news/new-crispr-cas9-technique-treats-cystic-fibrosis-in-human-stem-cells-468